These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3762645)

  • 1. Vasodilator therapy in congestive heart failure.
    N Engl J Med; 1986 Nov; 315(19):1227-8. PubMed ID: 3762645
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Veterans Administration Cooperative Study on Vasodilator Therapy of Heart Failure: influence of prerandomization variables on the reduction of mortality by treatment with hydralazine and isosorbide dinitrate.
    Cohn JN; Archibald DG; Francis GS; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Flohr KH
    Circulation; 1987 May; 75(5 Pt 2):IV49-54. PubMed ID: 3552302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of vasodilator drugs in congestive heart failure.
    Med Lett Drugs Ther; 1978 Oct; 20(20):89-91. PubMed ID: 703684
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Cohn JN
    Eur Heart J; 1988 Jan; 9 Suppl A():171-3. PubMed ID: 3044793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic use of vasodilators in the therapy of congestive cardiac insufficiency].
    Manfrin M; Frascione P; Budini A; Cesari GP; Colonna PL; Schicchi F; Chiesa R
    Minerva Med; 1982 Oct; 73(40):2741-4. PubMed ID: 7133486
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L; Higa SS
    Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of vasodilator agents in chronic heart failure].
    Bussmann WD
    Med Klin; 1981 Apr; 76(9):249-53. PubMed ID: 6456408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G; Kutschera I; Sauer E
    Dtsch Med Wochenschr; 1980 Oct; 105(40):1379-83. PubMed ID: 7449633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
    Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
    Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vasodilator agents in the treatment of heart failure].
    Prati PL; Manfrin M
    G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927
    [No Abstract]   [Full Text] [Related]  

  • 15. Current indications for vasodilator therapy for left ventricular failure.
    Franciosa JA
    Compr Ther; 1985 Mar; 11(3):39-46. PubMed ID: 2983926
    [No Abstract]   [Full Text] [Related]  

  • 16. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L; Branea I; Riviş I; Radivoievici A; Mancaş S; Păunescu A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):129-34. PubMed ID: 6139858
    [No Abstract]   [Full Text] [Related]  

  • 17. The Vasodilator-Heart Failure Trials (V-HeFT). Mechanistic data from the VA Cooperative Studies. Introduction.
    Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI1-4. PubMed ID: 8500232
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vasodilators in chronic heart insufficiency].
    Bucher HJ
    Schweiz Rundsch Med Prax; 1986 Jan; 75(4):61-3. PubMed ID: 3952406
    [No Abstract]   [Full Text] [Related]  

  • 19. [Vasodilator therapy by isosorbide dinitrate for the patients with congestive heart failure (author's transl)].
    Ogasawara B; Kai I; Kondo T; Watanabe E; Okubo M; Sassa H; Niwa T; Matsui E
    Nihon Naika Gakkai Zasshi; 1978 Jan; 67(1):24-34. PubMed ID: 632635
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of congestive cardiac failure with vasodilators (author's transl)].
    Hauf GF; Bubenheimer P; Lönne E; Roskamm H
    Dtsch Med Wochenschr; 1981 Nov; 106(48):1607-12. PubMed ID: 7307999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.